Otsuka enters deal with Mylan for Deltyba to treat MDR-TB Ruby Khatun Khatun27 Aug 2017 11:00 AM ISTTOKYO, HERTFORDSHIRE, England, and PITTSBURGH: Otsuka Pharmaceutical Co. Ltd. and Mylan NV have entered into a license agreement between their...
Kiran Mazumdar Shaw to lead Infy CEO search, may go back to alumni Ruby Khatun Khatun27 Aug 2017 10:30 AM ISTNew Delhi: Former Infoscions may well have a shot at clinching the top job as Infosys CEO, with the company looking at "alumni" along with internal...
Samsung, Biogen version of AbbVies Humira approved in Europe Ruby Khatun Khatun27 Aug 2017 10:30 AM ISTA biosimilar version of AbbVie Inc’s blockbuster arthritis drug Humira, produced by a joint venture of Biogen Inc and Samsung Biologics, was approved...
Novartis appoints Bertrand Bodson as Chief Digital Officer Ruby Khatun Khatun27 Aug 2017 9:30 AM ISTBasel: Novartis announced that Bertrand Bodson, Chief Digital and Marketing Officer for Sainsbury's Argos, has been appointed to the new role of Chief...
Adamas Pharma secures approval for Parkinsons dyskinesia drug Ruby Khatun Khatun27 Aug 2017 9:15 AM ISTThe U.S. Food and Drug Administration (FDA) said it had approved Adamas Pharmaceuticals Inc’s treatment for a side effect caused by a commonly...
FDA clears Novo Nordisk diabetes drug to treat heart diseases Ruby Khatun Khatun26 Aug 2017 11:00 AM ISTNovo Nordisk said on Friday the U.S. Food and Drug Administration (FDA) approved its diabetes drug as a treatment to reduce the risk of three major...
Cigna TTK Health to infuse Rs 114 crore for business expansion Ruby Khatun Khatun26 Aug 2017 10:15 AM ISTMumbai: Cigna TTK Health Insurance is planning to infuse Rs 114 crore to expand its business, increase distribution network and for upgrading...
PMDA completes SMS Pharma manufacturing facility inspection Ruby Khatun Khatun26 Aug 2017 10:00 AM ISTHyderabad: SMS Pharmaceuticals Limited has announced a successful inspection by Pharmaceuticals and Medical Devices Agency (PMDA), Japan Authorities,...
New data boosts case for extended use of AstraZeneca heart drug Ruby Khatun Khatun26 Aug 2017 9:30 AM ISTLONDON: AstraZeneca's blood-thinner Brilinta cuts the risk of cardiovascular death by 29 percent in patients with a history of past heart attacks who...
Lupin initiates recall of tablet Mibelas 24 Fe from US market Ruby Khatun Khatun25 Aug 2017 11:00 AM ISTHYDERABAD: Pharma major Lupin, through its USA subsidiary Lupin Pharmaceuticals, Inc has initiated a voluntary recall of tablets Mibelas 24 Fe from...
Glenmark gets USFDA nod for generic skin ointment Ruby Khatun Khatun25 Aug 2017 10:45 AM ISTNew Delhi: Glenmark Pharmaceuticals on Wednesday said it has received final approval from the US health regulator for generic Triamcinolone Acetonide...
Novartis receives EU approval for breast cancer drug Kisqali Ruby Khatun Khatun25 Aug 2017 10:30 AM ISTZURICH: Novartis AG said its drug Kisqali (ribociclib) received European Union approval as first-line treatment for a tough-to-treat breast cancer,...
